BioRem Balance Sheet Health
Financial Health criteria checks 5/6
BioRem has a total shareholder equity of CA$10.0M and total debt of CA$2.6M, which brings its debt-to-equity ratio to 25.8%. Its total assets and total liabilities are CA$24.4M and CA$14.4M respectively. BioRem's EBIT is CA$7.2M making its interest coverage ratio 30.2. It has cash and short-term investments of CA$7.3M.
Key information
25.8%
Debt to equity ratio
CA$2.57m
Debt
| Interest coverage ratio | 30.2x |
| Cash | CA$7.27m |
| Equity | CA$9.96m |
| Total liabilities | CA$14.42m |
| Total assets | CA$24.38m |
Recent financial health updates
BioRem (CVE:BRM) Has A Pretty Healthy Balance Sheet
Jan 25
Is BioRem (CVE:BRM) Using Too Much Debt?
Aug 26Here's Why BioRem (CVE:BRM) Can Manage Its Debt Responsibly
Mar 23BioRem (CVE:BRM) Could Easily Take On More Debt
Aug 25These 4 Measures Indicate That BIOREM (CVE:BRM) Is Using Debt Reasonably Well
May 20Recent updates
Investors Continue Waiting On Sidelines For BioRem Inc. (CVE:BRM)
Oct 11Solid Earnings May Not Tell The Whole Story For BioRem (CVE:BRM)
Apr 19BioRem Inc. (CVE:BRM) Soars 35% But It's A Story Of Risk Vs Reward
Apr 12BioRem (CVE:BRM) Has A Pretty Healthy Balance Sheet
Jan 25Is BioRem (CVE:BRM) Using Too Much Debt?
Aug 26Here's Why BioRem (CVE:BRM) Can Manage Its Debt Responsibly
Mar 23BioRem (CVE:BRM) Could Easily Take On More Debt
Aug 25These 4 Measures Indicate That BIOREM (CVE:BRM) Is Using Debt Reasonably Well
May 20Here's What's Concerning About BIOREM's (CVE:BRM) Returns On Capital
Jan 26Key Things To Understand About BIOREM's (CVE:BRM) CEO Pay Cheque
Nov 23
Financial Position Analysis
Short Term Liabilities: BRM's short term assets (CA$21.9M) exceed its short term liabilities (CA$11.4M).
Long Term Liabilities: BRM's short term assets (CA$21.9M) exceed its long term liabilities (CA$3.0M).
Debt to Equity History and Analysis
Debt Level: BRM has more cash than its total debt.
Reducing Debt: BRM's debt to equity ratio has increased from 0% to 25.8% over the past 5 years.
Debt Coverage: BRM's debt is well covered by operating cash flow (210.8%).
Interest Coverage: BRM's interest payments on its debt are well covered by EBIT (30.2x coverage).